# Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention

> **NCT00618436** · PHASE4 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 52 (actual)

## Conditions studied

- Traumatic Brain Injury
- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Phenytoin

## Key facts

- **NCT ID:** NCT00618436
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2014-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618436, "Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention". Retrieved via AI Analytics 2026-06-19 from https://api.ai-analytics.org/clinical/NCT00618436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*